Ionis Pharmaceuticals Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio7.839.219.135.3010.84
P/B Ratio9.3818.779.375.5710.64
Price/Tangible Book9.3818.779.375.5711.05
Price/FCF228.0310240.42
Price/OCF139.52220.26
Enterprise Value Ratios
EV/Revenue7.138.887.884.459.07
EV/FCF191.388569.00
Profitability & Returns
Return on Equity (ROE)-0.93%-0.76%-0.40%-0.04%-0.40%
Return on Assets (ROA)-0.10%-0.08%-0.10%-0.01%-0.04%
Return on Invested Capital (ROIC)-3.65%
Return on Capital Employed (ROCE)-0.18%-0.13%-0.18%-0.01%-0.10%
Leverage & Solvency Ratios
Debt/Equity3.335.092.391.621.26
Debt/FCF66.391217.15
Liquidity Ratios
Current Ratio8.475.907.079.753.56
Quick Ratio7.745.436.499.133.30
Efficiency Ratios
Asset Turnover0.230.280.230.320.26
Inventory Turnover91.4961.6636.1827.980.59
Yield & Distribution Ratios
Earnings Yield-0.08%-0.05%-0.05%-0.01%-0.06%
FCF Yield-0.10%-0.05%-0.05%0.00%0.00%
Buyback Yield-0.04%-0.01%-0.01%-0.01%0.09%